SCHEMBL13948350

SCHEMBL13948350

CCC(Cc1cc(Cl)ccc1C1CCN(C(=O)OC(C)(C)C)CC1)C(=O)N1CCCC1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ TP53 P04637 2/20 0.44
▸ POLB P06746 1/20 0.44
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ STS P08842 2/20 0.42
▸ CNR1 P21554 3/20 0.42
▸ NPSR1 Q6W5P4 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ DPP4 P27487 1/20 0.42
▸ USP2 O75604 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ FNTA P49354 2/20 0.41
▸ FNTB P49356 2/20 0.41
▸ MAPT P10636 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12713201 0.89 SMN1; SMN2 (0.46) SMN1; SMN2TP53POLBMEN1KMT2A
SCHEMBL12713212 0.88 TP53 (0.47) SMN1; SMN2TP53POLBMEN1KMT2A
SCHEMBL13002965 0.84 SMN1; SMN2 (0.44) SMN1; SMN2TP53POLBMEN1KMT2A
SCHEMBL12713213 0.84 SMN1; SMN2 (0.47) SMN1; SMN2TP53POLBMEN1KMT2A
SCHEMBL12713214 0.83 SMN1; SMN2 (0.46) SMN1; SMN2TP53POLBMEN1KMT2A
SCHEMBL12713199 0.82 SMN1; SMN2 (0.45) SMN1; SMN2TP53POLBMEN1KMT2A
SCHEMBL14436423 0.81 SMN1; SMN2 (0.47) SMN1; SMN2TP53POLBMEN1KMT2A
SCHEMBL12713138 0.81 SMN1; SMN2 (0.47) SMN1; SMN2TP53POLBMEN1KMT2A
SCHEMBL14401276 0.80 SMN1; SMN2 (0.47) SMN1; SMN2TP53POLBMEN1KMT2A
SCHEMBL12713153 0.79 SMN1; SMN2 (0.46) SMN1; SMN2TP53POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2020405-A1 Substituted aryl or heteroarylpiperidine derivatives as melanocortin-4 receptor modulators Santhera Pharmaceuticals (Schweiz) AG (CH) 2009-02-04 — — EP disclosed
Send feedback